Received: from 209.sub-70-209-196.myvzw.com ([70.209.196.209]:9232) by stodi.digitalkingdom.org with esmtp (Exim 4.87) (envelope-from ) id 1cxyG5-0007d9-Mo for lojban@lojban.org; Tue, 11 Apr 2017 09:03:14 -0700 Received: (from apache@localhost) by myvzw.com (8.14.7/8.14.7/Submit) id 80FD8B1445F378; Tue, 11 Apr 2017 09:03:03 -0700 Date: Tue, 11 Apr 2017 09:03:03 -0700 To: lojban From: Janice Rowland Reply-to: Janice Rowland Subject: FDA approval is about to send this stock up fifty fold Message-ID: <2d7f915093a0cd16d9a653e655bfacb0@localhost.localdomain> X-Priority: 3 MIME-Version: 1.0 Content-Transfer-Encoding: 8bit Content-Type: text/plain; charset="UTF-8" X-Spam-Score: 2.9 (++) X-Spam_score: 2.9 X-Spam_score_int: 29 X-Spam_bar: ++ X-Spam-Report: Spam detection software, running on the system "stodi.digitalkingdom.org", has NOT identified this incoming email as spam. The original message has been attached to this so you can view it or label similar future email. If you have any questions, see the administrator of that system for details. Content preview: Why is Quest Management (Symbol: QSMG) guaranteed to jump 5,000% this month? They have a cure for cancer. This biotech is run by some of the most prolific scientists in America. Together, they have more than 400 years of experience in the field and have more diplomas than we can even imagine. [...] Content analysis details: (2.9 points, 5.0 required) pts rule name description ---- ---------------------- -------------------------------------------------- 0.0 CK_HELO_DYNAMIC_SPLIT_IP Relay HELO'd using suspicious hostname (Split IP) 3.5 HELO_DYNAMIC_SPLIT_IP Relay HELO'd using suspicious hostname (Split IP) 0.0 RCVD_IN_SORBS_DUL RBL: SORBS: sent directly from dynamic IP address [70.209.196.209 listed in dnsbl.sorbs.net] -3.0 RP_MATCHES_RCVD Envelope sender domain matches handover relay domain -1.9 BAYES_00 BODY: Bayes spam probability is 0 to 1% [score: 0.0000] 3.3 RCVD_IN_PBL RBL: Received via a relay in Spamhaus PBL [70.209.196.209 listed in zen.spamhaus.org] 1.0 RDNS_DYNAMIC Delivered to internal network by host with dynamic-looking rDNS Why is Quest Management (Symbol: QSMG) guaranteed to jump 5,000% this month? They have a cure for cancer. This biotech is run by some of the most prolific scientists in America. Together, they have more than 400 years of experience in the field and have more diplomas than we can even imagine. Cancer kills 1 out of 4 people in our country and we have all been affected by it either directly or indirectly. Who doesn't know someone who's died from it? The company's scientists are targeting cancer using stem cells. They are able to identify the bad cells and destroy them without radiating the entire body (like is common with chemo). Apart from saving millions of lives, their treatment will surely become the No1 selling drug on earth. The company has already made serious headway thanks to nearly two decades of research. This cutting edge biotech company has completed animal trials successfully and just wrapped up FDA-approved human trials last week. The next step is the public announcement of those results, which we hear through the grapevine have beat all expectations and will change the world of medicine forever. The results will be announced this month, and once they are out the stock will jump to $25 a share overnight and will continue up to $50 or more quickly after. "Quest"'s biotech arm could have a cancer cure that can be totally effective in killing tumors in more than 40% of patients worldwide available in hospitals throughout the globe by the end of the year. Once that happens, we're talking about a $1000 a share stock. We're literally coming in at the last mile, out of no where, and grabbing profits from their last 2 decades of hard work. Consider buying QSMG right now while it's still at under 5 dollars and make sure to tell all your friends to do the same before the price explodes.